Monospecific Antipeptide Antibodies Against Human Hepatic UDP-Glucuronosyltransferase 1A Subfamily (UGT1A) Isoforms

スポンサーリンク

概要

論文の詳細を見る
2006-02-28

著者

関連論文

Monospecific Antipeptide Antibodies Against Human Hepatic UDP-Glucuronosyltransferase 1A Subfamily (UGT1A) Isoforms
ラット肝臓のシトクロムP450(P450)とUDP-グルクロン酸転移酵素(UGT)のタンパク間相互作用 : P450-UGT複合体中でUGTが活性を持つことの証明
Species difference among mice, hamsters, rats, and guinea pigs in phenobarbital-induced alteration of serum thyroxine level(Proceedings of the 32nd Annual Meeting)
Mechanistic study for the decrease in serum thyroxine level in PCB-treated mice(Proceedings of the 32nd Annual Meeting)
Blood-Brain Permeability of [^3H]-(3-methyl-His^2) Thyrotropin-releasing Hormone (MeTRH) in Mice : Effects of TRH and its Analogues
ROLE OF THE METHYL SULFONE-CONTAINING METABOLITES IN ALTERATIONS OF HEPATIC MICROSOMAL DRUG-METABOLIZING ENZYMES BY CHLORINATED BENZENES
P7-52 Mechanistic study for the decrease in serum thyroid hormone level in PCB-treated mice(ENDOCRINE AND NERVOUS SYSTEM)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
O-14 Species difference among mice, hamsters, rats, and guinea pigs in phenobarbital-induced alteration of serum thyroid hormone level(ENDOCRINE SYSTEM/DEVELOPMENT AND REPRODUCTION/CARCINOGENICITY/TOXICOGENOMICS)(GENERAL SESSION BY ORAL PRESENTATION)(Proc
Species difference among mice, hamsters, rats, and guinea pigs in 2,2',4',5,5'-pentachlorobiphenyl or 2,2',3',4',5,6-hexachlorobiphenyl-induced alteration of serum thyroid hormone level (ENDOCRINE SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedi
Species difference among mice, hamsters, rats, and guinea pigs in Kanechlor-500-induced alteration of serum thyroid hormone level (ENDOCRINE SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
Relation between the increase in hepatic UDP- GT and the decrease in serum thyroxine level in Kanechlor-500-treated rats.(GENERAL SESSION BY ORAL PRESENTATION)(ENDOCRINE SYSTEM)
The induction of hepatic microsomal UDP-glu-curonosyltransferase by the methylsulfonyl metabolites of 2,2',4',5-tetrabromobiphenyl in rats.(GENERAL SESSION BY ORAL PRESENTATION)(ENDOCRINE SYSTEM)
O12-15 Effects of 2, 2', 4', 5, 5'-Pentachlorobiphenyl and 2, 2', 3', 4', 5, 6-Hexachlorobiphenyl on Serum Hormone Levels in Rats and Mice
O12-13 Reduction of Serum Thyroxine Concentration by Methylsulfonyl Metabolites of Chlorobenzenes in Male Rats
O-33 In Vivo Metabolism of 2, 2', 4', 5, 5'-Pentachlorobiphenyl and Its Inductive Activity of Drug-Metabolizing Enzymes : Species Difference between Rats and Mice(Proceedings of the 27th Annual Meeting)
O-32 2, 2', 4', 5-Tetrabromobiphenyl Metabolite, 3-MeSO_2-2, 2', 4', 5-Tetrabromobiphenyl is a Potent Inducer of CYP2B1/2.(Proceedings of the 27th Annual Meeting)
Contribution of the 3-Methylsulfonyl Metabolite of 2,2', 4,5,5'-Pentachlorobiphenyl to Heme Metabolic Enzyme Induction by the Parent Compound in Rat Liver(PROCEEDINGS OF 24TH SYMPOSIUM ON TOXICOLOGY AND ENVIRONMENTAL HEALTH)
Reduction of Thyroid Hormone Levels by Methylsulfonyl Metabolites of PCB Congeners in Rats(PROCEEDINGS OF 24TH SYMPOSIUM ON TOXICOLOGY AND ENVIRONMENTAL HEALTH)
Tissue Distribution of Methylsulfonyl Metabolites Derived from 2,2', 4,4'-, 3,3', 4,4'-and 2,3', 4', 5-Tetrachlorobiphenyls in Rats (Proceedings of the 23rd Symposium on Toxicology and Environmental Health)
Induction of Hepatic Microsomal Drug-Metabolizing Enzymes by 3-Methylsulfonyl-2,2', 4', 5,5'-Pentachlorobiphenyl in Female Rats (Proceedings of the 23rd Symposium on Toxicology and Environmental Health)
Evidence That 3-Methylsulfonyl Metabolite of 2,2', 4,5,5'-Pentachlorobiphenyl Is Causative Substance of Induction of Hepatic Microsomal Drug-Metabolizing Enzymes by the Parent Compound in Rats (Proceedings of the 23rd Symposium on Toxicology and Environme
In Vivo Metabolism of Mono-Ortho Substituted Polychlorinated Biphenyls : Identification of Hydroxy and Methylsulfonyl Metabolites with Tissue Retention in Rats (Proceedings of the 23rd Symposium on Toxicology and Environmental Health)
In vivo Metabolism of 3,3', 4,4'-Tetrachlorobiphenyl in Rats : Occurrence and Liver-Specific Retention of Methylsulfonyl Metabolite (Proceedings of the 22nd Symposium on Toxicology and Environmental Health)
Effects of Methylsulfonyl Metabolites of PCBs Accumulated in Tissues of Mammals on Activities of Hepatic Microsomal Drug-Metabolizing Enzymes in Rats (Proceedings of the 19th Symposium on Toxicology and Environmental Health)
Nasal Absorption of Digoxin in Rats
Effects of Chlorobenzenes and Their Methyl Sulfone Metabolites on Microsomal Enzymes Associated with Drug Metabolism in Rat Liver
Influence of Royal Jelly on Mouse Hepatic Gene Expression and Safety Assessment with a DNA Microarray
ラットにおける PCB 同族体のメチルスルフォニル代謝物による甲状腺ホルモンレベルの減少
Effects of Sulfur-Containing Metabolites of Hexachlorobenzene on the Heme Metabolic Enzymes in Rat Liver
BILIARY METABOLITES OF m-DICHLOROBENZENE IN RATS
N_2 Fixation Variability in the Oligotrophic Sulu Sea, Western Equatorial Pacific Region over the Past 83 kyr
Spatial and temporal sea-surface temperatures in the eastern equatorial Pacific over the past 150 kyr
Development of Novel Vasoactive Intestinal Peptide Derivatives with Improved Stability : Physicochemical and Pharmacological Characterization
Protective Effects of PACAP and Its Analogs on Apoptotic Death of Rat Pancreatic β Cells
Transcriptional Enhancement of UDP-Glucuronosyltransferase Form 1A2 (UGT1A2) by Nuclear Factor I-A (NFI-A) in Rat Hepatocytes
Multiple organelle-targeting signals in the N-terminal portion of peroxisomal membrane protein PMP70
Inhalable powder formulation of vasoactive intestinal peptide derivatives, [R^, L^]-VIP-GRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats
Peroxisome Proliferator-Activated Receptor Subtypes Differentially Cooperate with Other Transcription Factors in Selective Transactivation of the Perilipin/PEX11α Gene Pair
Development of glucagon-loaded PLGA nanospheres for inhalation therapy with improved pharmacokinetics and pharmacodynamics
Inhalable powder formulation of stabilized vasoactive intestinal peptide derivative (IK312548)
Remobilization of Aresenic in Sub-Oxic Sediments from the Seafloor of the Continental Margin
Structural basis of species differences between human and experimental animal CYP1A1s in metabolism of 3,3',4,4',5-pentachlorobiphenyl
New PACAP38 Analogue with Improved Stability : Physicochemical and Biochemical Characterization
Development of Vasoactive Intestinal Peptide Derivative-Loaded PLGA Nanospheres with Improved Duration of Action
ATP-binding cassette transporter isoform C2 localizes to the apical plasma membrane via interactions with scaffolding protein
3,3',4,4'-Tetrachlorobiphenyl-Mediated Decrease of Serum Thyroxine Level in C57BL/6 and DBA/2 Mice Occurs Mainly through Enhanced Accumulation of Thyroxine in the Liver
Development of Inhalable Dry-emulsion Formulation of Cyclosporine A with Improved Anti-inflammatory Effects and Reduced Systemic Exposure

もっと見る

スポンサーリンク